Alpha Cognition Enrolls First Patient In RESOLVE, Phase 4 Post-Marketing Clinical Study To Further Evaluate Tolerability Profile, Treatment Experience Associated With ZUNVEYL In Routine Clinical Practice

뉴스 본문을 불러오고 있어요.

Alpha Cognition Enrolls First Patient In RESOLVE, Phase 4 Post-Marketing Clinical Study To Further Evaluate Tolerability Profile, Treatment Experience Associated With ZUNVEYL In Routine Clinical Practice | 웨이프 WAPE

Alpha Cognition Enrolls First Patient In RESOLVE, Phase 4 Post-Marketing Clinical Study To Further Evaluate Tolerability Profile, Treatment Experience Associated With ZUNVEYL In Routine Clinical Practice

기사 요약

관련 종목

댓글 —